Piribedil is an antiparkinsonian agent and piperazine derivative which acts as a D 2 and D 3 receptor agonist. It also has α 2 -adrenergic antagonist properties. [2][3] The drug has been …

吡贝地尔又称泰舒达、哌利必地、双哌嘧啶，是临床上常用的一种外周血管和脑血管扩张药，属多巴胺受体激动剂，可单一用药或与左旋多巴联合用药治疗帕金森病，改善老年人智能缺陷所致 …

吡贝地尔（INN： piribedil ）是一种抗帕金森病药物和哌嗪衍生物，可作为D 2 和D 3 受体激动剂。 它还具有 α 2 -肾上腺素受体 拮抗剂特性。 [ 2 ] [ 3 ]

2016年10月20日 · Piribedil is a dopamine agonist used with or without levodopa in the treatment of Parkinson's disease. Piribedil has been investigated in Parkinson's Disease. The next …

Piribedil is a piperazine derivative, a dopamine receptor agonist, which has been mainly used for the treatment of depression and Parkinson’s disease. It has also been recommended for the …

Piribedil is a potent and orally active dopamine D2 and dopamine D3 agonist. Piribedil is also a α2-adrenoceptors antagonist. Piribedil can inhibit MLL1 methyltransferase activity (EC50: 0.18 …

主要研究目的：按有关生物等效性试验的规定，选择Les Laboratoires Servier为持证商的吡贝地尔缓释片（商品名：泰舒达，规格：50mg）为参比制剂，对石家庄四药有限公司生产并提供的 …

Piribedil | C16H18N4O2 | CID 4850 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity …

2025年3月17日 · 吡贝地尔又称泰舒达、哌利必地、双哌嘧啶，是临床上常用的一种外周血管和脑血管扩张药，属多巴胺受体激动剂，可单一用药或与左旋多巴联合用药治疗帕金森病，改善老 …

2016年6月25日 · Piribedil acts as a non-ergot partial dopamine D2/D3-selective agonist, blocks alpha2-adrenoreceptors and has minimal effects on serotoninergic, cholinergic, and …